Alkermes price target lowered to $30 from $32 at Goldman Sachs

Oct 25, 2024 · Goldman Sachs lowered the firm’s price target on Alkermes (ALKS) to $30 from $32 and keeps a Buy rating on the shares. The company’s Q3 results included operating …

CouponFollow Extension

$30
OFF

Alkermes Price Target Lowered To $30 From $32 At Goldman Sachs

1 week from now

Oct 25, 2024 · Goldman Sachs lowered the firm’s price target on Alkermes (ALKS) to $30 from $32 and keeps a Buy rating on the shares. The company’s Q3 results included operating …

nasdaq.com

$30.00
OFF

Alkermes (NASDAQ:ALKS) PT Lowered To $30.00 | MarketBeat

1 week from now

Oct 25, 2024 · The Goldman Sachs Group dropped their target price on shares of Alkermes from $32.00 to $30.00 and set a "buy" rating for the company in a research note on Friday. ...

marketbeat.com

$32.00
OFF

The Goldman Sachs Group Trims Alkermes (NASDAQ:ALKS) Target …

1 week from now

Oct 28, 2024 · Alkermes (NASDAQ:ALKS – Free Report) had its target price trimmed by The Goldman Sachs Group from $32.00 to $30.00 in a report released on Friday morning, …

defenseworld.net

$30.00
OFF

Alkermes: Strong Buy Rating Amidst Short-term Challenges And …

1 week from now

Oct 25, 2024 · In another report released today, Goldman Sachs also maintained a Buy rating on the stock with a $30.00 price target. ... Alkermes price target lowered to $30 from $32 at …

businessinsider.com

$30.00
OFF

Alkermes Inc.: Strong Q3 Performance And Strategic Growth Drive …

1 week from now

Oct 27, 2024 · In another report released on October 25, Goldman Sachs also maintained a Buy rating on the stock with a $30.00 price target. ... Alkermes price target lowered to $30 from $32 …

businessinsider.com

$30
OFF

ALKS News Today | Why Did Alkermes Stock Go Down Today?

1 week from now

Nov 7, 2024 · Alkermes price target lowered to $30 from $32 at Goldman Sachs. October 26, 2024 | markets.businessinsider.com ... Given New $30.00 Price Target at The Goldman Sachs …

marketbeat.com

$30.00
OFF

Goldman Sachs Keeps Alkermes Stock Buy-rated Ahead Of …

1 week from now

Oct 25, 2024 · On Friday, Alkermes Plc (NASDAQ:ALKS) received an updated price target from Goldman Sachs, with the firm lowering its expectation to $30.00 from the previous $32.00, …

investing.com

$32.88
OFF

Alkermes (ALKS) Gets A Hold From J.P. Morgan - Markets Insider

1 week from now

Oct 26, 2024 · The company has a one-year high of $32.88 and a one-year low of $22.06. Currently, Alkermes has an average volume of 1.72M. ... Alkermes price target lowered to $30 …

businessinsider.com

57%
OFF

Alkermes Plc Buy The Goldman Sachs Group, Inc. - Sharewise

1 week from now

Oct 25, 2024 · In the thread Alkermes plc diskutieren. Prediction Buy. Perf. (%) 11.57%. Target price 27.759. Change. Ends at 25.10.25. Alkermes plc (NASDAQ: ALKS) had its price target …

sharewise.com

$32.62
OFF

What Is The Current Price Target And Forecast For Alkermes (ALKS)

1 week from now

Nov 6, 2024 · Goldman Sachs: Chris Shibutani: Strong Buy: Strong Buy: ... 8/30/2024: Evercore Partners: Umer Raffat: ... the average price target for Alkermes comes to $32.62. The …

zacks.com

$32
OFF

Alkermes Plc: Target Price Consensus And Analysts …

1 week from now

Oct 14, 2024 · JPMorgan Adjusts Price Target on Alkermes to $32 From $31, Maintains Neutral Rating Jul. 25: MT Baird Adjusts Price Target on Alkermes to $38 From $37, Maintains …

marketscreener.com

$35.42
OFF

Alkermes (ALKS) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

3 days ago · According to the 12 analysts' twelve-month price targets for Alkermes, the average price target is $35.42. ... The Goldman Sachs Group. 2 of 5 stars ... JPMorgan Chase & Co. …

marketbeat.com

$28
OFF

Alkermes Price Target Lowered To $28 From $29 At BofA - Nasdaq

1 week from now

Oct 25, 2024 · Try Now>>See Insiders’ Hot Stocks on TipRanks >> Read More on ALKS:Alkermes price target lowered to $43 from $48 at Cantor FitzgeraldAlkermes price target …

nasdaq.com

$28
OFF

Alkermes: Balancing Near-Term Challenges With Long-Term …

1 week from now

Oct 25, 2024 · Alkermes price target lowered to $28 from $29 at BofA; Alkermes price target lowered to $43 from $48 at Cantor Fitzgerald; Alkermes price target lowered to $30 from $32 …

businessinsider.com

$40.00
OFF

Mizuho Boosts Alkermes (NASDAQ:ALKS) Price Target To $40.00

1 week from now

1 day ago · The Goldman Sachs Group reduced their price objective on Alkermes from $32.00 to $30.00 and set a “buy” rating on the stock in a research report on Friday, October 25th.

defenseworld.net

$43
OFF

Alkermes Price Target Lowered To $43 From $48 At Cantor Fitzgerald

1 week from now

Alkermes price target lowered to $30 from $32 at Goldman Sachs; Alkermes price target lowered to $37 from $38 at Piper Sandler; Alkermes backs FY24 financial expectations; Alkermes …

tipranks.com

$128
OFF

Goldman Sachs Adjusts Valero Energy Price Target To $128 From …

1 week from now

7 hours ago · US fuelmakers to report lower Q3 profits on weaker margins, fuel demand Oct. 23: RE Goldman Sachs Adjusts Price Target on Valero Energy to $130 From $131, Maintains Sell …

marketscreener.com

$43
OFF

Alkermes Price Target Lowered To $43 From $48 At Cantor Fitzgerald

1 week from now

Oct 25, 2024 · Alkermes price target lowered to $30 from $32 at Goldman Sachs; Alkermes price target lowered to $37 from $38 at Piper Sandler; Alkermes backs FY24 financial expectations; …

businessinsider.com

$209.00
OFF

Allstate (NYSE:ALL) Stock Price Expected To Rise, The Goldman …

1 week from now

1 day ago · The Goldman Sachs Group raised their price target on shares of Allstate from $209.00 to $230.00 and gave the stock a "buy" rating in a report on Friday. ... valued at …

marketbeat.com

FAQs about Alkermes price target lowered to $30 from $32 at Goldman Sachs Coupon?

Should you buy Alkermes (AlkS)?

Robert W. Baird analyst Joel Beatty maintained a Buy rating on Alkermes (ALKS – Research Report) yesterday and set a price target of $38.00. Joel Beatty has given his Buy rating due to a combination of factors that highlight Alkermes’ potential for continued profitability despite some upcoming challenges. ...

What is Cantor Fitzgerald's price target on Alkermes (AlkS)?

Read More on ALKS: Cantor Fitzgerald lowered the firm’s price target on Alkermes (ALKS) to $43 from $48 and keeps an Overweight rating on the shares. Alkerme... ...

Why has Joel Beatty rated Alkermes a buy?

Joel Beatty has given his Buy rating due to a combination of factors that highlight Alkermes’ potential for continued profitability despite some upcoming challenges. The company’s revenue for the third quarter was almost in line with expectations, driven largely by strong sales of Vivitrol. ...

Why did Marc Goodman give Alkermes a hold rating?

Marc Goodman has given his Hold rating due to a combination of factors affecting Alkermes. First, the company’s recent financial performance was largely in line with expectations, although both revenues and expenses were slightly lower than anticipated. This balance did not significantly impact the overall outlook. ...

How did Alkermes perform in third-quarter 2024?

The company’s third-quarter 2024 results were robust, primarily driven by the impressive performance of Vivitrol, which exceeded expectations. Despite a slight miss in overall revenue primarily due to anticipated shifts in manufacturing revenues, Alkermes managed to surpass consensus forecasts for non-GAAP EPS. ...

What does Alkermes stand for?

Begin your TipRanks Premium journey today. Alkermes (ALKS) Company Description: Alkermes Plc is a biopharmaceutical company, which engages in the development, research, and commercialization of medicines that are designed to address unmet medical needs of patients in major therapeutic areas. ...